Zobrazeno 1 - 10
of 276
pro vyhledávání: '"García-Bermejo L"'
Autor:
Urbanova M; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska Cesta 9, 845 05 Bratislava, Slovakia., Cihova M; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska Cesta 9, 845 05 Bratislava, Slovakia., Buocikova V; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska Cesta 9, 845 05 Bratislava, Slovakia., Slopovsky J; 2nd Department of Oncology, National Cancer Institute, Klenova 1, 833 10 Bratislava, Slovakia; Faculty of Medicine, Comenius University, Spitalska 24, 813 72 Bratislava, Slovakia., Dubovan P; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska Cesta 9, 845 05 Bratislava, Slovakia; Department of Surgical Oncology, National CancerInstitute in Bratislava, Klenova 1, 833 10 Bratislava, Slovakia; Faculty of Medicine, Slovak Medical University in Bratislava, Limbová12, 833 03 Bratislava., Pindak D; Department of Surgical Oncology, National CancerInstitute in Bratislava, Klenova 1, 833 10 Bratislava, Slovakia; Faculty of Medicine, Slovak Medical University in Bratislava, Limbová12, 833 03 Bratislava., Tomas M; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska Cesta 9, 845 05 Bratislava, Slovakia; Department of Surgical Oncology, National CancerInstitute in Bratislava, Klenova 1, 833 10 Bratislava, Slovakia; Faculty of Medicine, Slovak Medical University in Bratislava, Limbová12, 833 03 Bratislava., García-Bermejo L; Biomarkers and Therapeutic Targets Group, Area4, Ramón y Cajal Health Research Institute (IRYCIS), Carretera Colmenar Km 9100, 28034 Madrid, Spain., Rodríguez-Garrote M; Molecular Epidemiology and Predictive Tumor Markers Group, Area 3, Ramón y Cajal Health Research Institute (IRYCIS), Carretera Colmenar Km 9100, 28034 Madrid, Spain; CIBERONC, Madrid, Spain., Earl J; Molecular Epidemiology and Predictive Tumor Markers Group, Area 3, Ramón y Cajal Health Research Institute (IRYCIS), Carretera Colmenar Km 9100, 28034 Madrid, Spain; CIBERONC, Madrid, Spain., Kohl Y; Department Bioprocessing & Bioanalytics, Fraunhofer Institute for Biomedical Engineering IBMT, 66280 Sulzbach, Germany., Kataki A; 1st Department of Propaedeutic Surgery, National and Kapodistrian University of Athens, Vasilissis Sofias 114, 11527 Athens, Greece., Dusinska M; Health Effects Laboratory, Department of Environmental Chemistry, NILU-Norwegian Institute for Air Research, Instituttveien 18, 2002 Kjeller, Norway., Sainz B Jr; CIBERONC, Madrid, Spain; Instituto de Investigaciones Biomédicas'Alberto Sols' (IIBM), CSIC-UAM, 28029 Madrid, Spain; Biomarkers and Personalized Approach to Cancer (BIOPAC) Group, Area 3, Ramón y Cajal Health Research Institute (IRYCIS), 28034 Madrid, Spain., Smolkova B; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska Cesta 9, 845 05 Bratislava, Slovakia., Gabelova A; Department of Nanobiology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska Cesta 9, 84505 Bratislava, Slovakia.. Electronic address: alena.gabelova@savba.sk.
Publikováno v:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Sep; Vol. 165, pp. 115179. Date of Electronic Publication: 2023 Jul 21.
Autor:
Úbeda M; Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain., Maza MDC; Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain., Delgado P; Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain., Horndler L; Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain., Abia D; Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain., García-Bermejo L; Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Madrid, Spain., Serrano-Villar S; Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Madrid, Spain., Calvo C; Department of Pediatrics, Tropical and Infectious Diseases, Hospital La Paz, and La Paz Research Institute (IdiPAZ), Translational Research Network of Pediatric Infectious Diseases (RITIP), and CIBERINFEC, Madrid, Spain., Bastolla U; Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain., Sainz T; Department of Pediatrics, Tropical and Infectious Diseases, Hospital La Paz, and La Paz Research Institute (IdiPAZ), Translational Research Network of Pediatric Infectious Diseases (RITIP), and CIBERINFEC, Madrid, Spain., Fresno M; Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain.; Instituto Sanitario Princesa, Madrid, Spain.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Mar 03; Vol. 14, pp. 1105237. Date of Electronic Publication: 2023 Mar 03 (Print Publication: 2023).
Autor:
Alonso-Nocelo M; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Ruiz-Cañas L; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Sancho P; Translational Research Unit, Hospital Miguel Servet, Instituto de Investigacion Sanitaria Aragon, Zaragoza, Spain., Görgülü K; Comprehensive Cancer Center München, Klinikum rechts der Isar der Technischen Universität München, München, Germany., Alcalá S; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Pedrero C; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Vallespinos M; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., López-Gil JC; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Ochando M; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., García-García E; Departamento de Anatomía Patológica, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain., David Trabulo SM; Stem Cells and Cancer Group, Molecular Pathology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Martinelli P; Institute for Cancer Research, Comprehensive Cancer Center, Medizinische Universitat Wien, Wien, Austria., Sánchez-Tomero P; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Sánchez-Palomo C; Departamento de Anatomía, Histologia y Neurociencia, Universidad Autónoma de Madrid, Madrid, Spain., Gonzalez-Santamaría P; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer and Human Molecular Genetics, Instituto de Investigación Sanitaria IdiPAZ, Madrid, Spain., Yuste L; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Cancer and Human Molecular Genetics, Instituto de Investigación Sanitaria IdiPAZ, Madrid, Spain., Wörmann SM; Ahmed Cancer Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kabacaoğlu D; Comprehensive Cancer Center München, Klinikum rechts der Isar der Technischen Universität München, München, Germany., Earl J; Molecular Epidemiology and Predictive Tumor Markers Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain, Madrid, Spain.; Gastrointestinal Tumours Research Programme, Biomedical Research Network in Cancer (CIBERONC), Madrid, Spain., Martin A; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain., Salvador F; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain., Valle S; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Martin-Hijano L; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Carrato A; Molecular Epidemiology and Predictive Tumor Markers Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain, Madrid, Spain.; Gastrointestinal Tumours Research Programme, Biomedical Research Network in Cancer (CIBERONC), Madrid, Spain.; Alcala University, Madrid, Spain., Erkan M; University Research Center for Translational Medicine - KUTTAM, Istanbul, Turkey., García-Bermejo L; Biomarkers and Therapeutic Targets Group, Area 4, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Hermann PC; Department of Internal Medicine I, Ulm University, Ulm, Germany., Algül H; Comprehensive Cancer Center München, Klinikum rechts der Isar der Technischen Universität München, München, Germany., Moreno-Bueno G; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer and Human Molecular Genetics, Instituto de Investigación Sanitaria IdiPAZ, Madrid, Spain.; Breast Cancer Research Programme, Biomedical Research Network in Cancer (CIBERONC), Madrid, Spain.; Fundación MD Anderson Internacional, Madrid, Spain., Heeschen C; Stem Cells and Cancer Group, Molecular Pathology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Center for Single-Cell Omics and Key Laboratory of Oncogenes and Related Genes, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Portillo F; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Breast Cancer Research Programme, Biomedical Research Network in Cancer (CIBERONC), Madrid, Spain., Cano A; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer and Human Molecular Genetics, Instituto de Investigación Sanitaria IdiPAZ, Madrid, Spain.; Breast Cancer Research Programme, Biomedical Research Network in Cancer (CIBERONC), Madrid, Spain., Sainz B , Jr; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain bsainz@iib.uam.es.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Gastrointestinal Tumours Research Programme, Biomedical Research Network in Cancer (CIBERONC), Madrid, Spain.
Publikováno v:
Gut [Gut] 2023 Feb; Vol. 72 (2), pp. 345-359. Date of Electronic Publication: 2022 Apr 15.
Autor:
Alcalá, S., Sancho, P., Martinelli, P., Navarro, D., Pedrero, C., Martín-Hijano, L., Valle, S., Earl, J., Rodríguez-Serrano, M., Ruiz-Cañas, L., Rojas, K., Carrato, A., García-Bermejo, L., Fernández-Moreno, M.Á., Hermann, P.C., Sainz, B., Jr.
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Biblos-e Archivo: Repositorio Institucional de la UAM
Universidad Autónoma de Madrid
Nature Communications, Vol 11, Iss 1, Pp 1-17 (2020)
Biblos-e Archivo. Repositorio Institucional de la UAM
Nature Communications
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Zaguán: Repositorio Digital de la Universidad de Zaragoza
Universidad de Zaragoza
instname
Biblos-e Archivo: Repositorio Institucional de la UAM
Universidad Autónoma de Madrid
Nature Communications, Vol 11, Iss 1, Pp 1-17 (2020)
Biblos-e Archivo. Repositorio Institucional de la UAM
Nature Communications
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Zaguán: Repositorio Digital de la Universidad de Zaragoza
Universidad de Zaragoza
Pancreatic cancer stem cells (PaCSCs) drive pancreatic cancer tumorigenesis, chemoresistance and metastasis. While eliminating this subpopulation of cells would theoretically result in tumor eradication, PaCSCs are extremely plastic and can successfu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97bdde1660260304ea8300e895e97904
http://hdl.handle.net/10261/222247
http://hdl.handle.net/10261/222247
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Maza MDC; Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain., Úbeda M; Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain.; Instituto Sanitario Princesa, Madrid, Spain., Delgado P; Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain., Horndler L; Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain., Llamas MA; EMPIREO Diagnóstico Molecular Sociedad Limitada (SL), Madrid, Spain., van Santen HM; Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain., Alarcón B; Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain., Abia D; Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain., García-Bermejo L; Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Universidad de Alcalá, Madrid, Spain., Serrano-Villar S; Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Universidad de Alcalá, Madrid, Spain., Bastolla U; Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain., Fresno M; Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain.; Instituto Sanitario Princesa, Madrid, Spain.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Mar 23; Vol. 13, pp. 836516. Date of Electronic Publication: 2022 Mar 23 (Print Publication: 2022).
Autor:
Oldoni E; European Infrastructure for Translational Medicine (EATRIS), Amsterdam, The Netherlands., van Gool A; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., García Bermejo L; Department of Pathology, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Scherer A; Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland., Mayrhofer MT; Biobanking and BioMolecular Resources Research Infrastructure-European Research Infrastructure Consortium (BBMRI-ERIC), Graz, Austria., Florindi F; Biobanking and BioMolecular Resources Research Infrastructure-European Research Infrastructure Consortium (BBMRI-ERIC), Graz, Austria., Demotes J; European Clinical Research Infrastructures Network (ECRIN), Paris, France., Kubiak C; European Clinical Research Infrastructures Network (ECRIN), Paris, France., Fauvel AC; European Infrastructure for Translational Medicine (EATRIS), Amsterdam, The Netherlands., Bietrix F; European Infrastructure for Translational Medicine (EATRIS), Amsterdam, The Netherlands., Ussi A; European Infrastructure for Translational Medicine (EATRIS), Amsterdam, The Netherlands., Andreu AL; European Infrastructure for Translational Medicine (EATRIS), Amsterdam, The Netherlands.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 May 18; Vol. 72 (10), pp. 1838-1842.
Autor:
Alvarez Rodríguez, S., Blanco Agudo, C., Gómez Dos Santos, V., García Bermejo, L., Lorca Álvaro, J., Hevia Palacios, V., Santiago Gónzalez, M., Díez Nicolás, V., Burgos Revilla, F.J.
Publikováno v:
In European Urology Open Science July 2020 19 Supplement 2:e2193-e2193
Autor:
Miguel V; Program of Physiological and Pathological Processes, Centro de Biología Molecular 'Severo Ochoa' (CSIC-UAM), 28049, Madrid, Spain. Electronic address: vmiguel@cbm.csic.es., Ramos R; Genomic Facility, Parque Científico de Madrid, Madrid, Spain., García-Bermejo L; Department of Pathology, Hospital Universitario 'Ramón y Cajal', IRYCIS, Madrid, Spain., Rodríguez-Puyol D; Department of Medicine and Medical Specialties, Research Foundation of the University Hospital 'Príncipe de Asturias,' IRYCIS, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain., Lamas S; Program of Physiological and Pathological Processes, Centro de Biología Molecular 'Severo Ochoa' (CSIC-UAM), 28049, Madrid, Spain. Electronic address: slamas@cbm.csic.es.
Publikováno v:
Redox biology [Redox Biol] 2021 Apr; Vol. 40, pp. 101851. Date of Electronic Publication: 2020 Dec 28.